Which closed-end funds own Teva Pharm Fnc Nl II?
2 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $663K. Security type: debt security. Country: Netherlands. ISIN XS2592804194.
Holdings are historical filings (report dates Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| EVV Eaton Vance Ltd Duration Income Fund | Taxable Bonds | 0.03% | $530K | 395,000 par | $1.7B | 13.5% discount | Jun 30, 2026 |
| HYT BlackRock Corporate High Yield Fund | High Yield | 0.01% | $134K | 100,000 par | $2.5B | 11.3% discount | Jun 30, 2026 |
2 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Related securities from the same issuer
| Security | Type | Funds holding |
|---|---|---|
| Teva Pharmaceutical Finance Netherlands III Bv | debt security | 12 |
| Teva Pharmaceutical Finance Netherlands III Bv | debt security | 11 |
| Teva Pharmaceutical Finance Netherlands III Bv | debt security | 10 |
| Teva Pharmaceutical Finance Netherlands III Bv | debt security | 7 |
| Teva Pharmaceutical Industries Ltd | common equity | 6 |
| Teva Pharmaceutical Finance Netherlands III Bv | debt security | 5 |
| Teva Pharmaceutical Indu | debt security | 3 |
| Teva Pharm Fin IV | debt security | 3 |
| Teva Pharm Fnc Nl II | debt security | 2 |
| Teva Pharmaceutical Finance Company LLC | debt security | 2 |
| Teva Pharmaceuticals Ne | debt security | 1 |
| Teva Pharmaceutical Finance Netherlands II B.V. | debt security | 1 |
Issuer-level search for “TEVA PHARM FNC NL II” → · Compare two funds’ portfolios →